Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses

10.1016/j.cell.2006.02.015

S. E. Collins, K. L. Mossman, Danger, diversity and priming in innate antiviral immunity. Cytokine Growth Factor Rev. 25, 525–531 (2014).

10.1038/nri2079

M. Yoneyama, T. Fujita, RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227, 54–65 (2009).

G. Chen, M. H. Shaw, Y.-G. Kim, G. Nuñez, NOD-like receptors: Role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4, 365–398 (2009).

10.1016/j.coi.2010.12.015

10.1016/j.immuni.2011.05.003

10.1016/j.cell.2005.08.012

10.1038/ni.2091

10.1073/pnas.1311669110

10.1126/science.1232458

10.1038/ni921

10.1038/cr.2016.40

10.1016/j.cell.2005.11.007

10.1016/j.cell.2009.04.042

10.1038/embor.2008.136

10.1074/jbc.M110.109819

S. Ning, J. S. Pagano, The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J. Virol. 84, 6130–6138 (2010).

S. Panda, J. A. Nilsson, N. O. Gekara, Deubiquitinase MYSM1 regulates innate immunity through inactivation of TRAF3 and TRAF6 complexes. Immunity 43, 647–659 (2015).

J. Cui, Y. Song, Y. Li, Q. Zhu, P. Tan, Y. Qin, H. Y. Wang, R.-F. Wang, USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 24, 400–416 (2014).

Y. Fan, R. Mao, Y. Yu, S. Liu, Z. Shi, J. Cheng, H. Zhang, L. An, Y. Zhao, X. Xu, Z. Chen, M. Kogiso, D. Zhang, H. Zhang, P. Zhang, J. U. Jung, X. Li, G. Xu, J. Yang, USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J. Exp. Med. 211, 313–328 (2014).

A. B. Kahn, M. C. Ryan, H. Liu, B. R. Zeeberg, D. C. Jamison, J. N. Weinstein, SpliceMiner: A high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis. BMC Bioinformatics 8, 75 (2007).

10.1016/j.cell.2010.03.040

10.1016/j.immuni.2012.11.013

S. Jin, S. Tian, Y. Chen, C. Zhang, W. Xie, X. Xia, J. Cui, R. F. Wang, USP19 modulates autophagy and antiviral immune responses by deubiquitinating Beclin-1. EMBO J. 35, 866–880 (2016).

10.1074/jbc.M109.074971

10.1016/j.molcel.2016.08.029

S. Daubeuf, D. Singh, Y. Tan, H. Liu, H. J. Federoff, W. J. Bowers, K. Tolba, HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113, 3264–3275 (2009).

A. Colleran, P. E. Collins, C. O’Carroll, A. Ahmed, X. Mao, B. McManus, P. A. Kiely, E. Burstein, R. J. Carmody, Deubiquitination of NF-κB by ubiquitin-specific protease-7 promotes transcription. Proc. Natl. Acad. Sci. U.S.A. 110, 618–623 (2013).

10.1016/j.molcel.2016.08.025

10.1038/cr.2016.125

E. M. Cooper, C. Cutcliffe, T. Z. Kristiansen, A. Pandey, C. M. Pickart, R. E. Cohen, K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J. 28, 621–631 (2009).

10.1038/ncomms15534

10.1126/sciadv.1701764

K. Zhao, Q. Zhang, X. Li, D. Zhao, Y. Liu, Q. Shen, M. Yang, C. Wang, N. Li, X. Cao, Cytoplasmic STAT4 promotes antiviral type I IFN production by blocking CHIP-mediated degradation of RIG-I. J. Immunol. 196, 1209–1217 (2016).

I. E. Wertz, K. M. O’Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D. L. Boone, A. Ma, E. V. Koonin, V. M. Dixit, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694–699 (2004).

10.1038/cr.2016.39

10.1084/jem.20151531

Y. Qin, Q. Liu, S. Tian, W. Xie, J. Cui, R.-F. Wang, TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1. Cell Res. 26, 613–628 (2016).

10.1038/ni.3580